Pramipexole extended release: in Parkinson's disease.
Chwieduk
Claudine M
CM
Adis, a Wolters Kluwer Business, North Shore, Auckland, New Zealand. demail@adis.co.nz
Curran
Monique P
MP
D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D052160:Benzothiazoles / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D000077487:Pramipexole; D016896:Treatment Outcome
D000978:Antiparkinson Agents; D052160:Benzothiazoles; D003692:Delayed-Action Preparations; D000077487:Pramipexole